Please assess the completion status of the following clinical trial:

Trial Title: Self-administered Lidocaine Gel for Pain-control During Cervical Preparation for Dilation and Evacuation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women 18 and older~* Intrauterine pregnancy ≥16 weeks gestation~* English speaking competency~* Willing and able to sign consent forms~* Agree to comply with study procedures~Exclusion Criteria:~* Women less than 18 years of age~* IV conscious sedation~* Known allergy to study medication (lidocaine)~* Any women not meeting inclusion criteria above will be excluded from participation

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Self-administered Gel (Type: EXPERIMENTAL): Patient-administered, vaginal lidocaine gel (2%)--inserted 15 minutes prior to cervical preparation procedure
- Paracervical Block (Type: ACTIVE_COMPARATOR): Provider-administered lidocaine (1%) paracervical injection--administered immediately prior to tenaculum placement

Based on this trial design, predict the completion outcome and termination type (if applicable).